BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

874 related articles for article (PubMed ID: 26764125)

  • 1. The effect of on-site and outreach-based needle and syringe programs in people who inject drugs in Kermanshah, Iran.
    Nazari SS; Noroozi M; Soori H; Noroozi A; Mehrabi Y; Hajebi A; Sharifi H; Higgs P; Mirzazadeh A
    Int J Drug Policy; 2016 Jan; 27():127-31. PubMed ID: 26764125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do needle and syringe programs reduce risky behaviours among people who inject drugs in Kermanshah City, Iran? A coarsened exact matching approach.
    Noroozi M; Marshall BDL; Noroozi A; Armoon B; Sharifi H; Farhoudian A; Ghiasvand H; Vameghi M; Rezaei O; Sayadnasiri M; Pouya RH
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S303-S308. PubMed ID: 29271013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of HIV Status Notification on Risk Behaviors among Men Who Inject Drugs in Kermanshah, West of Iran.
    Noroozi A; Mirzazadeh A; Farhoudian A; Hajebi A; Khankeh HR; Higgs P; Sharifi H; Armoon B; Noroozi M
    J Res Health Sci; 2016; 16(3):116-121. PubMed ID: 27840338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Needle and Syringe Programs and HIV-Related Risk Behaviors Among Men Who Inject Drugs: A Multilevel Analysis of Two Cities in Iran.
    Noroozi M; Noroozi A; Sharifi H; Harouni GG; Marshall BDL; Ghisvand H; Qorbani M; Armoon B
    Int J Behav Med; 2019 Feb; 26(1):50-58. PubMed ID: 30460445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Needle and syringe sharing practices among injecting drug users in Tehran: a comparison of two neighborhoods, one with and one without a needle and syringe program.
    Zamani S; Vazirian M; Nassirimanesh B; Razzaghi EM; Ono-Kihara M; Mortazavi Ravari S; Gouya MM; Kihara M
    AIDS Behav; 2010 Aug; 14(4):885-90. PubMed ID: 18483849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updates on syringe coverage and service uptake among needle and syringe programs in the United States, 2019-2020.
    Tookes HE; Bartholomew TS; Sugar SES; Plesons MD; Bluthenthal RN; Wenger LD; Patel SV; Kral AH; Lambdin BH
    Int J Drug Policy; 2024 Jan; 123():104289. PubMed ID: 38071932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews.
    Palmateer N; Kimber J; Hickman M; Hutchinson S; Rhodes T; Goldberg D
    Addiction; 2010 May; 105(5):844-59. PubMed ID: 20219055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in Reported Injection Behaviors Following the Public Health Response to an HIV Outbreak Among People Who Inject Drugs: Indiana, 2016.
    Dasgupta S; Broz D; Tanner M; Patel M; Halleck B; Peters PJ; Weidle PJ; O'Donnell J; Amlung J; McAlister C; Chapman E; Bailey A; Burnett J; Duwve J
    AIDS Behav; 2019 Dec; 23(12):3257-3266. PubMed ID: 31313095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for better harm reduction: evaluating implementation of best practice recommendations for needle and syringe programs (NSPs).
    Strike C; Watson TM; Lavigne P; Hopkins S; Shore R; Young D; Leonard L; Millson P
    Int J Drug Policy; 2011 Jan; 22(1):34-40. PubMed ID: 20413288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
    Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis.
    Aspinall EJ; Nambiar D; Goldberg DJ; Hickman M; Weir A; Van Velzen E; Palmateer N; Doyle JS; Hellard ME; Hutchinson SJ
    Int J Epidemiol; 2014 Feb; 43(1):235-48. PubMed ID: 24374889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of pharmacy-based needle/syringe exchange programme for people who inject drugs: a systematic review and meta-analysis.
    Sawangjit R; Khan TM; Chaiyakunapruk N
    Addiction; 2017 Feb; 112(2):236-247. PubMed ID: 27566970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in sources and sharing of needles among people who inject drugs, San Francisco, 2005-2012.
    Kim NJ; Jin H; McFarland W; Raymond HF
    Int J Drug Policy; 2015 Dec; 26(12):1238-43. PubMed ID: 26365768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of syringe lending among HIV-positive people who inject drugs in Bangkok, Thailand.
    Voon P; Hayashi K; Ti L; Kaplan K; Suwannawong P; Wood E; Kerr T
    Harm Reduct J; 2015 Jun; 12():16. PubMed ID: 26032673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived acceptability of and willingness to use syringe vending machines: results of a cross-sectional survey of out-of-service people who inject drugs in Tbilisi, Georgia.
    Otiashvili D; Kirtadze I; Vardanashvili I; Tabatadze M; Ober AJ
    Harm Reduct J; 2019 Mar; 16(1):21. PubMed ID: 30898120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of sharing of needles and syringes among people who inject drugs in Dhaka city, Bangladesh.
    Hemel MM; Reza MM; Shafiq TK; Kabir MI; Rana AM; Khan SI
    J Infect Dev Ctries; 2021 Oct; 15(10):1497-1506. PubMed ID: 34780373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accessibility of Needle and Syringe Programs and Injecting and Sharing Risk Behaviors in High Hepatitis C Virus Prevalence Settings.
    Naserirad M; Beulaygue IC
    Subst Use Misuse; 2020; 55(6):900-908. PubMed ID: 31918611
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of a pilot study on needle and syringe exchange program among injecting drug users in a community in Guangdong, China].
    Lin P; Fan ZF; Yang F; Wu ZY; Wang Y; Liu YY; Ming ZQ; Li WJ; Luo W; Fu XB; Mai XR; Xu RH; Feng WY; He Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):305-8. PubMed ID: 15498241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida.
    Bartholomew TS; Feaster DJ; Patel H; Forrest DW; Tookes HE
    J Subst Abuse Treat; 2021 Aug; 127():108344. PubMed ID: 34134863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.